Biohack Blueprint · DoNotAge Conferences

Conference stage mechanisticPrimary source linked

CDK4/6 & Inflammaging: Rebecca Sumner at DoNotAge Conference 2026

Rebecca Sumner’s DoNotAge Conference 2026 presentation on CDK4/6, cell division and inflammatory regulation, currently classified as conference-stage mechanistic research.

By Dr. Khaled Mahmoud, MBBChPublished Last verified 1 min read
CDK4/6inflammagingcell divisioninflammatory regulationageing biology
DoNotAge Conference 2026 Watch Conference Highlights
Primary source for this analysis Open the original source ↗
Evidence contextConference presentations can discuss preliminary, unpublished or mixed-status findings. This page separates the presentation claim from evidence that can be independently verified.

Rebecca Sumner’s DoNotAge Conference 2026 presentation brought cell-cycle biology into the inflammaging discussion, linking CDK4/6 activity, cell division and inflammatory regulation.

Who is Rebecca Sumner?

King’s College London lists Dr Rebecca Sumner as a Lecturer in host/pathogen interactions in the Department of Infectious Diseases. Her research includes innate immune sensing, host-cell responses to DNA and interactions between viruses and those pathways.

What the conference highlights establish

The official DoNotAge Conference 2026 highlights connect Sumner’s contribution with CDK4/6, cell division and inflammatory control. The mechanistic interpretation remains conference-stage unless the specific result is matched to a peer-reviewed paper, preprint or formal abstract.

Why the connection is interesting

Ageing biology overlaps with innate immunity, DNA sensing, cellular senescence and altered inflammatory signalling. A mechanism linking cell-cycle regulation to inflammatory state could therefore be relevant to several ageing pathways, but mechanistic relevance is not the same as demonstrating a therapeutic intervention.

What this does not establish

The conference presentation does not establish that modifying CDK4/6 is a proven anti-ageing therapy or that a particular drug or supplement should be used to target this pathway. Clinical relevance requires evidence beyond a conference-stage mechanistic result.

Sources

Official DoNotAge Conference 2026 highlights

King’s College London — Rebecca Sumner profile

Return to the 2026 conference hub.

Linked entities and research

Event2026

DoNotAge Conference 2026

DoNotAge Conference 2026 was held in London on September 26–27, 2026. The official highlights archive presents 12 2026 conversations spanning human trials, DNA repair, inflammation, muscle and exercise, replication and research funding, plus a 2025 conference recap.

Conference talkLab/cell mechanistic evidence. The closest identifiable source for the CDK4/6/type-I-interferon mechanism is bioRxiv preprint doi:10.1101/2023.04.15.537049, which is not peer reviewed. No human aging or intervention-efficacy evidence is established.

Why Aging Cells Can Keep Inflammation Switched On

The related preprint reports that dividing cells suppress part of the type I interferon/innate immune response in a CDK4/6-linked manner. The possible connection to persistent inflammation in aging is mechanistic and hypothesis-generating rather than clinical evidence.

Talk source ↗

PersonKing's College London

Rebecca Sumner

DoNotAge Conference 2026 speaker. No separate DoNotAge-funded Rebecca Sumner research project was independently identified in the reviewed sources as of October 10, 2026.